Treace Medical Concepts, Inc. (TMCI) stock
TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3016% below fair value
$5.27−0.07 (-1.31%)
Close on Nov 13, 2026Market cap $342.73MP/E –Yield –
Treace Medical Concepts operating margin
Operating margin is operating income as a percentage of revenue.
Treace Medical Concepts's operating margin for the twelve months ending Sep 30, 2026 was -24.4%. For fiscal 2025 it was -25.5%, against -26.6% the year before. The highest annual figure on record is 1.5% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -25.5% | +1.1 |
| FY2024 | Dec 31, 2024 | -26.6% | +0.9 |
| FY2023 | Dec 31, 2023 | -27.5% | −2.9 |
| FY2022 | Dec 31, 2022 | -24.6% | −7.1 |
| FY2021 | Dec 31, 2021 | -17.5% | −19.0 |
| FY2020 | Dec 31, 2020 | 1.5% | +10.5 |
| FY2019 | Dec 31, 2019 | -9.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -23.9% | +7.3 |
| Q2 FY2026 | Jun 30, 2026 | -33.0% | +2.9 |
| Q1 FY2026 | Mar 31, 2026 | -36.4% | −6.7 |
| Q4 FY2025 | Dec 31, 2025 | -9.5% | −9.2 |
| Q3 FY2025 | Sep 30, 2025 | -31.2% | +2.3 |
| Q2 FY2025 | Jun 30, 2025 | -35.8% | +12.3 |
| Q1 FY2025 | Mar 31, 2025 | -29.6% | +7.5 |
| Q4 FY2024 | Dec 31, 2024 | -0.3% | +10.6 |
| Q3 FY2024 | Sep 30, 2024 | -33.6% | +10.1 |
| Q2 FY2024 | Jun 30, 2024 | -48.1% | −17.0 |
| Q1 FY2024 | Mar 31, 2024 | -37.1% | −4.5 |
| Q4 FY2023 | Dec 31, 2023 | -10.9% | −3.9 |
| Q3 FY2023 | Sep 30, 2023 | -43.7% | −9.5 |
| Q2 FY2023 | Jun 30, 2023 | -31.1% | +8.7 |
| Q1 FY2023 | Mar 31, 2023 | -32.6% | −4.8 |
| Q4 FY2022 | Dec 31, 2022 | -7.0% | +9.7 |
| Q3 FY2022 | Sep 30, 2022 | -34.2% | −9.0 |
| Q2 FY2022 | Jun 30, 2022 | -39.8% | −20.2 |
| Q1 FY2022 | Mar 31, 2022 | -27.9% | −20.4 |
| Q4 FY2021 | Dec 31, 2021 | -16.7% | −31.8 |
| Q3 FY2021 | Sep 30, 2021 | -25.3% | −24.8 |
| Q2 FY2021 | Jun 30, 2021 | -19.6% | +0.0 |
| Q1 FY2021 | Mar 31, 2021 | -7.5% | +3.2 |
| Q4 FY2020 | Dec 31, 2020 | 15.1% | – |
| Q3 FY2020 | Sep 30, 2020 | -0.4% | – |
| Q2 FY2020 | Jun 30, 2020 | -19.6% | – |
| Q1 FY2020 | Mar 31, 2020 | -10.7% | – |
See a number that looks wrong?